Latest debt-to-equity ratio

Rigel Pharmaceuticals Debt-to-equity ratio

Direct answer

Rigel Pharmaceuticals's debt-to-equity ratio is 9.39%.

The verified market snapshot reports 9.39%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 5, 2026.

Get free Rigel Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Debt-to-equity ratio
9.39%

Explore related company data

View Rigel Pharmaceuticals's market capitalizationView Rigel Pharmaceuticals's p/e ratioView Rigel Pharmaceuticals's price-to-book ratioView Rigel Pharmaceuticals's return on equityView Rigel Pharmaceuticals's dividend yieldView Rigel Pharmaceuticals's 52-week price rangeView Rigel Pharmaceuticals's revenue growthView Rigel Pharmaceuticals's profit marginView all Rigel Pharmaceuticals key metricsReturn to Rigel Pharmaceuticals profile